Effect of mixed umbilical cord blood plasma on the culture of human umbilical vein endothelial cells
Zhi Li
Abstract
Zhi Li
Abstract
Objective: To observe the effect of mixed umbilical cord blood plasma on the culture of human umbilical vein endothelia cells (HUVEC). Methods: Primary and passaged HUVEC were cultured in the medium with 20% mixed umbilical cord blood plasma and their purities were evaluated by Ⅷ:Ag and UEA Ⅰ.Proliferative activities of HUVEC were compared in the medium containing different amounts of mixed umbilical cord blood plasma by methyl thiazolyl tetrazolium(MTT) assay. Results: 20% mixed umbilical cord blood plasma can maintain cell viability in the medium without endothelial cell growth factor(ECGF). The purity of endothelial cells was 93.1%. Conclusion: 20 portion mixed umbilical cord blood plasma can be a substitute for ECGF and used successfully in the culture of HUVEC to obtain high purity and passagable endothelial cells.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To observe the effect of mixed umbilical cord blood plasma on the culture of human umbilical vein endothelia cells (HUVEC). Methods: Primary and passaged HUVEC were cultured in the medium with 20% mixed umbilical cord blood plasma and their purities were evaluated by Ⅷ:Ag and UEA Ⅰ.Proliferative activities of HUVEC were compared in the medium containing different amounts of mixed umbilical cord blood plasma by methyl thiazolyl tetrazolium(MTT) assay. Results: 20% mixed umbilical cord blood plasma can maintain cell viability in the medium without endothelial cell growth factor(ECGF). The purity of endothelial cells was 93.1%. Conclusion: 20 portion mixed umbilical cord blood plasma can be a substitute for ECGF and used successfully in the culture of HUVEC to obtain high purity and passagable endothelial cells.
Key concepts: Umbilical cord, Umbilical vein, Andrology, Placenta cord banking, Medicine, Human umbilical vein endothelial cell, Immunology, Chemistry